Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui et al. · Hepatology · 2023 · 2.3K citations · Full text

Medicine, Pediatrics, Hepatology +13

Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis

Zhenhua Wu, Shimeng Huang, Tiantian Li et al. · Microbiome · 2021 · 681 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice

Mousumi Bose, Joshua D. Lambert, Jihyeung Ju et al. · Journal of Nutrition · 2008 · 609 citations

Medicine, Biochemistry, Pharmacology +17

Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial

I-Ju Chen, Chia-Yu Liu, Jung-Peng Chiu et al. · Clinical Nutrition · 2015 · 327 citations

Medicine, Nutritional Sciences, Pharmacology +9

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

Jun Shirakawa, Hideki Fujii, Kei Ohnuma et al. · Diabetes · 2011 · 248 citations · Full text

Medicine, Endocrinology, Pharmacology +17